Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
Burkhard, P., Dominici, P., Borri-Voltattorni, C., Jansonius, J.N., Malashkevich, V.N.(2001) Nat Struct Biol 8: 963-967
- PubMed: 11685243 
- DOI: 10.1038/nsb1101-963
- Primary Citation of Related Structures:  
1JS3, 1JS6 - PubMed Abstract: 
DOPA decarboxylase (DDC) is responsible for the synthesis of the key neurotransmitters dopamine and serotonin via decarboxylation of L-3,4-dihydroxyphenylalanine (L-DOPA) and L-5-hydroxytryptophan, respectively. DDC has been implicated in a number of clinic disorders, including Parkinson's disease and hypertension ...